FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fougera Pharmaceuticals Fluocinonide Gel Recall

FLUOCINONIDE GEL USP, 0

Fougera Pharmaceuticals Inc. · Melville, NY

Risk level
Class II
Reported by FDA
Nov 19, 2014
Recall ID
D-0245-2015
Check your lot numberHow we source this data

Summary

Fougera Pharmaceuticals recalled Fluocinonide Gel starting Aug 28, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0245-2015 on Nov 19, 2014. Reason: Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>. Status: Terminated.

Why it was recalled

Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.

Product description

FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)

Lot numbers, UPCs & expiration codes

a) 15 gram lot numbers: 549N, 550N,551N Exp. 1/2015, EB1961, Exp. 2/2017; b) 60 gram lot numbers: 546N, 547N, 548N, Exp. 1/2015, EB0144, Exp. 2/2017

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0245-2015
Classification
Class II
Status
Terminated
Recall initiated
Aug 28, 2014
FDA report date
Nov 19, 2014
Quantity
a) 59,622 Tubes; b) 43,178 Tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Fougera Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0245-2015, exactly as published.

Show all FDA fields
City
Melville
State
NY
Status
Terminated
Country
United States
Event ID
68839
Address
60 Baylis Rd
Code information
a) 15 gram lot numbers: 549N, 550N,551N Exp. 1/2015, EB1961, Exp. 2/2017; b) 60 gram lot numbers: 546N, 547N, 548N, Exp. 1/2015, EB0144, Exp. 2/2017
Postal code
11747-3838
Report date
Nov 19, 2014
Product type
Drugs
Recall number
D-0245-2015
Classification
Class II
Recalling firm
Fougera Pharmaceuticals Inc.
Product quantity
a) 59,622 Tubes; b) 43,178 Tubes
Termination date
Jun 21, 2016
Reason for recall
Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.
Voluntary / mandated
Voluntary: Firm initiated
Product description
FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Aug 28, 2014
Initial firm notification
Letter
Center classification date
Nov 12, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0245-2015, published Nov 19, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls